252 related articles for article (PubMed ID: 29263022)
1. Cathepsin D plays a role in endothelial-pericyte interactions during alteration of the blood-retinal barrier in diabetic retinopathy.
Monickaraj F; McGuire P; Das A
FASEB J; 2018 May; 32(5):2539-2548. PubMed ID: 29263022
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin D: an Mϕ-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy.
Monickaraj F; McGuire PG; Nitta CF; Ghosh K; Das A
FASEB J; 2016 Apr; 30(4):1670-82. PubMed ID: 26718887
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation.
Lee CS; Kim YG; Cho HJ; Park J; Jeong H; Lee SE; Lee SP; Kang HJ; Kim HS
Sci Rep; 2016 Jul; 6():29393. PubMed ID: 27381080
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Jun HO; Yu YS; Kim KW
Am J Pathol; 2010 Mar; 176(3):1517-24. PubMed ID: 20110406
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of D-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats.
Jiang H; Zhang H; Jiang X; Wu S
Diabetologia; 2021 Mar; 64(3):693-706. PubMed ID: 33319325
[TBL] [Abstract][Full Text] [Related]
6. Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies.
Lupo G; Motta C; Giurdanella G; Anfuso CD; Alberghina M; Drago F; Salomone S; Bucolo C
Biochem Pharmacol; 2013 Dec; 86(11):1603-13. PubMed ID: 24076420
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy.
Hu J; Dziumbla S; Lin J; Bibli SI; Zukunft S; de Mos J; Awwad K; Frömel T; Jungmann A; Devraj K; Cheng Z; Wang L; Fauser S; Eberhart CG; Sodhi A; Hammock BD; Liebner S; Müller OJ; Glaubitz C; Hammes HP; Popp R; Fleming I
Nature; 2017 Dec; 552(7684):248-252. PubMed ID: 29211719
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
[TBL] [Abstract][Full Text] [Related]
11. Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier.
McGuire PG; Rangasamy S; Maestas J; Das A
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e107-15. PubMed ID: 21940944
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy.
Rangasamy S; Monickaraj F; Legendre C; Cabrera AP; Llaci L; Bilagody C; McGuire P; Das A
Exp Eye Res; 2020 Jun; 195():108043. PubMed ID: 32376470
[TBL] [Abstract][Full Text] [Related]
13. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy.
Rangasamy S; Srinivasan R; Maestas J; McGuire PG; Das A
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3784-91. PubMed ID: 21310918
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1β induces pericyte apoptosis via the NF-κB pathway in diabetic retinopathy.
Yun JH
Biochem Biophys Res Commun; 2021 Mar; 546():46-53. PubMed ID: 33571904
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine aggravates blood-retinal barrier breakdown of diabetic retinopathy via inhibition of intercellular communication in retinal pericytes.
Huang CY; Zhou T; Li G; Li MY; Xiong XM; Wu MT; Jiang JL
Amino Acids; 2019 Nov; 51(10-12):1515-1526. PubMed ID: 31576457
[TBL] [Abstract][Full Text] [Related]
16. Plastic roles of pericytes in the blood-retinal barrier.
Park DY; Lee J; Kim J; Kim K; Hong S; Han S; Kubota Y; Augustin HG; Ding L; Kim JW; Kim H; He Y; Adams RH; Koh GY
Nat Commun; 2017 May; 8():15296. PubMed ID: 28508859
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
18. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling.
Gurnik S; Devraj K; Macas J; Yamaji M; Starke J; Scholz A; Sommer K; Di Tacchio M; Vutukuri R; Beck H; Mittelbronn M; Foerch C; Pfeilschifter W; Liebner S; Peters KG; Plate KH; Reiss Y
Acta Neuropathol; 2016 May; 131(5):753-73. PubMed ID: 26932603
[TBL] [Abstract][Full Text] [Related]
20. Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
Cai J; Ruan Q; Chen ZJ; Han S
Future Med Chem; 2012 Nov; 4(17):2163-76. PubMed ID: 23190105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
